Previous studies have demonstrated that lysozymes exert protective effects against Aβ pathology in Drosophila melanogaster, AD mouse models, and human AD cases.[20, 21, 22] Evidence suggests that lysozymes can bind to Aβ, potentially influencing its aggregation and clearance and thereby impacting one of the primary pathological features of AD. Here, LYZ is linked to Alzheimer disease.